Abstract
Background: Emergence of resistance to some antibiotics in Haemophilus influenzae, a respiratory pathogen is a cause of concern. The aim is to study the antibiotic susceptibility pattern of Haemophilus isolates from respiratory infections with reference to beta-lactam resistance.
Methods: This is a laboratory based prospective study done in the department of microbiology in a tertiary care center after institutional ethics committee clearance. Haemophilus influenzae isolates from respiratory tract specimens over a period of one year were subjected to antibiotic susceptibility tests. Beta-lactamase production was detected by nitrocefin disc. hpd gene, blaTEM and blaROB genes were detected by PCR. The data was analysed using SPSS 11.5 version.
Results: Of the 162 isolates, 89.5% were from sputum specimens. Ampicillin resistance was seen in 5 (3.09%) isolates. The ampicillin resistant strains were positive for beta-lactamase enzyme and blaTEM gene. BLNAR and isolates with blaROB gene were not found.
Conclusion: In case of Haemophilus influenzae respiratory tract infection empirical treatment with amoxicillin clavulanate or third generation cephalosporin may be the drugs of choice in our geographic area.
Keywords: Haemophilus, ROB, TEM, respiratory pathogen, sputum specimens, Haemophilus influenzae.
Infectious Disorders - Drug Targets
Title:Occurrence of blaTEM and blaROB in Haemophilus species Causing Respiratory Tract Infections
Volume: 20 Issue: 3
Author(s): Prerna Khurana and Suchitra Shenoy*
Affiliation:
- Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka 576104,India
Keywords: Haemophilus, ROB, TEM, respiratory pathogen, sputum specimens, Haemophilus influenzae.
Abstract:
Background: Emergence of resistance to some antibiotics in Haemophilus influenzae, a respiratory pathogen is a cause of concern. The aim is to study the antibiotic susceptibility pattern of Haemophilus isolates from respiratory infections with reference to beta-lactam resistance.
Methods: This is a laboratory based prospective study done in the department of microbiology in a tertiary care center after institutional ethics committee clearance. Haemophilus influenzae isolates from respiratory tract specimens over a period of one year were subjected to antibiotic susceptibility tests. Beta-lactamase production was detected by nitrocefin disc. hpd gene, blaTEM and blaROB genes were detected by PCR. The data was analysed using SPSS 11.5 version.
Results: Of the 162 isolates, 89.5% were from sputum specimens. Ampicillin resistance was seen in 5 (3.09%) isolates. The ampicillin resistant strains were positive for beta-lactamase enzyme and blaTEM gene. BLNAR and isolates with blaROB gene were not found.
Conclusion: In case of Haemophilus influenzae respiratory tract infection empirical treatment with amoxicillin clavulanate or third generation cephalosporin may be the drugs of choice in our geographic area.
Export Options
About this article
Cite this article as:
Khurana Prerna and Shenoy Suchitra *, Occurrence of blaTEM and blaROB in Haemophilus species Causing Respiratory Tract Infections, Infectious Disorders - Drug Targets 2020; 20 (3) . https://dx.doi.org/10.2174/1871526519666190118103148
DOI https://dx.doi.org/10.2174/1871526519666190118103148 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy
Current Pharmaceutical Biotechnology Chemoinfectomics in Drug Design and Development
Anti-Infective Agents Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia
CNS & Neurological Disorders - Drug Targets Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Editorial: “Phytochemicals for Human Diseases: An Update”
Current Drug Targets Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience Substance P in Rheumatic Diseases
Current Rheumatology Reviews In Vivo Activity of Optimized Apidaecin and Oncocin Peptides Against a Multiresistant, KPC-Producing Klebsiella pneumoniae Strain
Protein & Peptide Letters Patent Selections:
Recent Patents on Regenerative Medicine Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Current Pharmaceutical Design Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Current Cancer Drug Targets Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Syphilis and HIV Co-Infection: When is Lumbar Puncture Indicated?
Current HIV Research Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Synthesis of New α-Amino Phosphonates Containing 3-Amino-4(3H) Quinazolinone Moiety as Anticancer and Antimicrobial Agents: DFT, NBO, and Vibrational Studies
Current Organic Synthesis